BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 19, 2010
View Archived Issues
Xcellerex initiates phase I trial of yellow fever vaccine
Read More
TGen Drug Development and Critical Outcome Technologies to collaborate on COTI-2
Read More
FDA grants Octapharma's Wilate orphan drug exclusivity for von Willebrand's disease
Read More
Karolinska Development and BioChromix form BioChromix Pharma
Read More
BioCryst achieves enrollment target in pivotal forodesine study
Read More
Novavax reports results from preclinical study of RSV vaccine in rats
Read More
CeNeRx BioPharma reports clinical results on CXB-722 in disorders of central nervous system
Read More
VaxInnate licenses recombinant H1N1 vaccine to Biological E. in India
Read More
New agents partially inhibit PDE4 and display reduced toxicity
Read More
Spherix completes enrollment into phase III trial of D-tagatose in type 2 diabetes
Read More
mTOR inhibition restores age-impaired hematopoietic stem cell function
Read More
NP-04634 shows anticonvulsant activity in rodent model of status epilepticus
Read More
Alogliptin equally effective in younger and elderly patients with type 2 diabetes
Read More
Trillium grants Biogen Idec exclusive worldwide rights to its development program
Read More
European orphan drug status recommended for Protalix's taliglucerase alfa for GD
Read More
FDA extends review period for OSI's sNDA for Tarceva in non-small cell lung cancer
Read More
Celgene acquires Gloucester Pharmaceuticals
Read More
Genentech claims checkpoint kinase Chk1 inhibitors for cancer therapy
Read More
GlaxoSmithKline presents PI3K inhibitors for treatment of asthma and COPD
Read More
Novel PPAR agonists claimed by sanofi-aventis as antidiabetic agents
Read More
Takeda's orally disintegrating Actos tablets approved in Japan for type 2 diabetes
Read More
Stearoyl-CoA desaturase inhibitors for treatment of acne claimed by GlaxoSmithKline
Read More
Merck & Co. discovers fatty-acid amide hydrolase inhibitors for postherpetic neuralgia
Read More
Novel protein kinase inhibitors for the treatment of cancer presented by sanofi-aventis
Read More
Bayer Yakuhin and Hospira Japan enter marketing agreement for Shinbit
Read More